Eli Lilly (LLY) earnings Q1 2025

Eli Lilly (LLY) earnings Q1 2025

The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg | Getty Images Eli Lilly on Thursday reported first-quarter revenue and earnings that topped estimates as demand for its weight loss and diabetes drugs soared, but lowered its full-year profit…

Read More
Eli Lilly (LLY) earnings Q4 2024

Eli Lilly (LLY) earnings Q4 2024

Eli Lilly on Thursday reported mixed results for the fourth quarter, even as sales of its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soared. The company’s quarterly earnings topped Wall Street estimates, but sales fell just short as Mounjaro saw lower realized prices. Zepbound and Mounjaro have now underperformed expectations for two straight…

Read More
Back To Top